Autopsy report · NCT01499043
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
Cause of deathFunding or business
“Business decision.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 10 months before it stopped.
- 6 participants enrolled.
- Results were posted on the registry 6 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Daiichi Sankyo
- Sponsor type
- Industry
- Conditions
- Prostate Cancer
- Interventions
- PLX3397
- Participants
- 6
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.